Home/Filings/4/0001104659-22-012918
4//SEC Filing

Mattessich Antony C. 4

Accession 0001104659-22-012918

CIK 0001393434other

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 7:28 PM ET

Size

16.1 KB

Accession

0001104659-22-012918

Insider Transaction Report

Form 4
Period: 2022-02-03
Mattessich Antony C.
DirectorPresident and C.E.O.
Transactions
  • Award

    Common Stock

    2022-02-03+186,750289,650 total
  • Award

    Stock Option (Right to Buy)

    2022-02-03+560,200560,200 total
    Exercise: $5.27Exp: 2032-02-02Common Stock (560,200 underlying)
Footnotes (3)
  • [F1]On February 3, 2022, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service to the Company, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter.
  • [F2]Includes 186,750 shares of common stock of the Company underlying unvested RSUs.
  • [F3]Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.

Issuer

OCULAR THERAPEUTIX, INC

CIK 0001393434

Entity typeother

Related Parties

1
  • filerCIK 0001709900

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 7:28 PM ET
Size
16.1 KB